Nudges to steer college students toward healthier beverage choices

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial tests whether simple nudges—health warnings, hedonic labeling, or both—can influence beverage choices in a classroom setting. Participants are randomly assigned to one of four groups: no-nudge control, health warnings, hedonic labeling, or combined health warning plus hedonic labeling. The study uses a between-subjects design to compare the impact of these strategies on selecting sugar-sweetened versus sugar-free beverages. The intervention is low-cost and unobtrusive, focused on promoting healthier beverage selections without restricting options.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* college students
* willing to participate

Exclusion Criteria:

none

Where it's running

• Nanjing Medical University
  Nanjing, Jiangsu, China Recruiting

Study contacts

• Study coordinator: Yuan He
• Email: heyuan@njmu.edu.cn
• Phone: 18651625286

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding how sleep affects metabolism and weight gain

  This study is testing how not getting enough sleep and the timing of sleep can affect metabolism and weight gain in people.

  Recruiting Oregon Health and Science University · Portland, Oregon · NCT05775627

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.